SHARE BASED PAYMENTS (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of share-based payment expense

The following table presents share-based payment expense for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Restricted stock	$	1,201	$	645
Stock options	43		308
Warrants	339		374
Total	$	1,583	$	1,327

Schedule of company’s outstanding stock purchase warrants

Restricted stock activity for the three months ended March 31, 2022 is presented in the following table:

	Shares	Weighted Average Grant Date Fair Value
Nonvested, December 31, 2021	483,750	$	20.19
Granted	595,500	$	10.84
Vested	(247,000)	$	4.40
Forfeited	(13,750)	$	5.72
Nonvested, March 31, 2022	818,500	$	18.18

Schedule of company’s outstanding stock purchase warrants

The table below summarizes all option activity under all plans during the three months ended March 31, 2022:

Options	Shares	Weight - Average Exercise Price		Weighted - Average Remaining Contractual Term	Weighted - Average Grant Date Fair Value
Outstanding at December 31, 2021	906,425	$	4.38	2.85	$	2.45
Granted	—	—		—	—
Exercised	—	—		—	—
Forfeited or expired	(187,427)	5.12		—	2.89
Outstanding at March 31, 2022	718,998	$	4.02	2.59	$	4.02
Options vested at March 31, 2022	679,000	$	4.35	2.52	$	2.44

Schedule of company’s outstanding stock purchase warrants

A summary of the status of the Company’s outstanding stock purchase warrants for the three months ended March 31, 2022 is as follows:

	Warrants	Weighted Average Exercise Price
Outstanding at December 31, 2021	330,884	$	22.14
Issued	—	—
Exercised	—	—
Forfeited	—	—
Outstanding at March 31, 2022	330,884	$	22.14